September 1, 2011 – Results from CREDO-Kyoto PCI/CABG Registry Cohort-2 show that percutaneous coronary intervention ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.
August 31, 2011 — Results of a recent randomized controlled study show the drug-eluting stent Xience V performs well in ...
August 25, 2011 – The U.S. Food and Drug Administration (FDA) has released its list of pre-market approval (PMA) and 510 ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
August 17, 2011 — OrbusNeich announced its Genous stent showed no significant difference in target vessel failure (TVF) ...
August 17, 2011 – Abbott announced today that the first patient in Japan has been treated with the Absorb bioresorbable ...
August 10, 2011 — Hospitals vary markedly when it comes to the rate at which diagnostic coronary angiography or ...
August 10, 2011 – The U.S. Food and Drug Administration (FDA) has approved Abbott’s RX Herculink Elite Renal Stent ...
August 9, 2011 — Boston Scientific Corp. said the U.S. Court of Appeals for the First Circuit has affirmed the dismissal ...
August 2, 2011 – The U.S. Food and Drug Administration said it recently cleared Abbott Vascular’s RX Herculink Elite ...
July 29, 2011 — InspireMD Inc., developer of the MGuard mesh protective stent system, announced that the first patient ...
July 29, 2011 — Boston Scientific Corporation's board of directors has approved a five-year, $150 million investment to ...
July 27, 2011 – Micell Technologies Inc. announced that it has completed patient enrollment in its DESSOLVE II CE mark ...
July 26, 2011 – The Resolute drug-eluting stent (DES) from Medtronic Inc. showed superiority to Boston Scientific Corp ...
April 26, 2011 – The U.S. Food and Drug Administration (FDA) announced this week it cleared Boston Scientific’s Ion ...
July 20, 2011 — IDEV Technologies Inc. announced the completion of enrollment in the SUPERB trial, a U.S. Food and Drug ...